kidney cancer

Aveo Screwed Up but Its Kidney Cancer Drug Is Real
TheStreet.com
Wed, 05/15/13 - 10:37 am
kidney cancer
Aveo Oncology
tivozanib
Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players
Motley Fool
Mon, 05/6/13 - 09:12 am
kidney cancer
ONYX Pharmaceuticals
Bayer
Nexavar
Roche
Avastin
Inlyta
Sutent
Pfizer
Votrient
GSK
Afinitor
Novartis
BMS-936558
Bristol-Myers Squibb
tivozanib
Aveo Oncology
Aveo, Delcath FDA Panel Live Blog
TheStreet.com
Thu, 05/2/13 - 10:52 am
FDA
advisory panels
tivozanib
Delcath
Aveo Oncology
kidney cancer
Melblez
Aveo Kidney Cancer Drug May Need More Study, FDA Says
Bloomberg
Tue, 04/30/13 - 09:46 am
kidney cancer
FDA
Aveo Pharmaceuticals
tivozanib
Why Aveo's Kidney Cancer Drug Will Be Turned Down By Next Week's FDA Panel
TheStreet.com
Thu, 04/25/13 - 09:25 am
Aveo Pharmaceuticals
kidney cancer
FDA
advisory panels
tivozanib
AVEO to meet with FDA about tivozanib
Bizjournals.com
Thu, 02/28/13 - 11:33 am
FDA
Aveo
tivozanib
kidney cancer
Aveo Pharma Readies Survival Update For Kidney Cancer Drug
TheStreet.com
Mon, 02/4/13 - 11:22 am
Aveo Pharmaceutical
kidney cancer
tivozanib
Pfizer cancer pill Inlyta gets EU approval for kidney cancer after failure of first treatment
Yahoo/AP
Tue, 09/4/12 - 12:24 pm
Pfizer
kidney cancer
Inlyta
Europe
Cramer: What Celgene’s Europe News Means
CNBC
Sat, 06/23/12 - 12:00 pm
Celgene
Revlimid
ONYX Pharmaceuticals
kidney cancer
liver cancer
Bristol Immune Drug Success In Cancer May Spur Industry Race
Bloomberg
Mon, 06/4/12 - 06:03 pm
Bristol-Myers Squibb
lung cancer
skin cancer
kidney cancer
Bristol-Myers Immune Drug Puts Deadly Cancers on Hold in Study
Bloomberg
Sun, 06/3/12 - 11:18 am
skin cancer
Bristol-Myers Squibb
BMS-936558
kidney cancer
lung cancer
Pfizer says EU advisory panel recommends approval for its advanced kidney cancer drug Inlyta
Yahoo/AP
Fri, 05/25/12 - 11:15 am
Inlyta
Pfizer
Europe
kidney cancer
Drug Fails: At Least It's Approved Already
Motley Fool
Thu, 05/17/12 - 10:17 am
Motley Fool
Pfizer
Torisel
Sutent
kidney cancer
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wed, 05/16/12 - 12:27 pm
ASCO
Genentech
T-DM1
breast cancer
tivozanib
Aveo
kidney cancer
Onyx
Bayer
regorafenib
colorectal cancer
Adcetris
Seattle Genetics
JNJ
prostate cancer
Zytiga
cabozantinib
Exelixis
Enzalutamide
Medivation
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
India licenses generic copy of patented Bayer drug
Yahoo/AP
Mon, 03/12/12 - 05:45 pm
Bayer
generics
India
liver cancer
kidney cancer
sorefinib
Natco
FDA clears Pfizer drug for advanced kidney cancer
Yahoo/AP
Sat, 01/28/12 - 11:45 am
Pfizer
kidney cancer
renal cell carcinoma
Inlyta
AVEO: More Open Questions Than Answers
Seeking Alpha
Sun, 01/8/12 - 12:47 pm
Aveo Pharmaceutical
tivozanib
kidney cancer
renal cancer
Pfizer’s Kidney Cancer Drug May Not Be Effective, FDA Says
Bloomberg
Mon, 12/5/11 - 09:31 am
FDA
Pfizer
kidney cancer
Axitinib
Commonly Used Pain Pills Increase Kidney Cancer Risk in Study
Bloomberg
Mon, 09/12/11 - 05:48 pm
kidney cancer
ibuprofen
JNJ
Pfizer
Bayer
naproxen
Pfizer says it asked European Union to approve its kidney cancer drug candidate axitinib
Yahoo/AP
Wed, 06/1/11 - 07:49 am
kidney cancer
Pfizer
Europe
Axitinib

Pages